glyburide has been researched along with Hyperlipemia in 21 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to examine the effect of the antihyperglycemic agents metformin (insulin sensitizer) and glibenclamide (insulin secretory agent) on the serum level of C-reactive protein (CRP) in well-controlled type 2 diabetics with metabolic syndrome." | 9.10 | Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome. ( Akbar, DH, 2003) |
| "To investigate the relationship between insulin resistance, postprandial hyperglycemia, postprandial hyperlipidemia, and oxidative stress in type 2 diabetes, changes in postprandial glucose, triglyceride, and nitrotyrosine levels vs baseline after diet loading were examined in type 2 diabetic patients given pioglitazone (PG) or glibenclamide (GB)." | 5.12 | Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes. ( Itoh, Y; Mori, Y; Obata, T; Tajima, N, 2006) |
| "The objective of this study was to examine the effect of the antihyperglycemic agents metformin (insulin sensitizer) and glibenclamide (insulin secretory agent) on the serum level of C-reactive protein (CRP) in well-controlled type 2 diabetics with metabolic syndrome." | 5.10 | Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome. ( Akbar, DH, 2003) |
| "In type 2 diabetic patients, the vasodilating response to forearm ischemia was the same whether patients were treated with diet treatment alone or with glibenclamide or glimepiride at blood glucose-lowering equipotent closes." | 5.09 | Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia. ( Brunelli, C; Cordera, R; Cordone, S; Olivotti, L; Rossettin, P; Schiavo, M; Spallarossa, P, 2001) |
| "Diabetes mellitus type 2 with dyslipidemia is a common disease." | 2.77 | Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. ( Dabaghian, FH; Hajiaghaee, R; Huseini, HF; Kianbakht, S, 2012) |
| "Hyperlipidemia is an associated complication of diabetes and also a major risk factor for cardiovascular diseases." | 1.40 | Antidiabetic and antihyperlipidemic activity of asiatic acid in diabetic rats, role of HMG CoA: in vivo and in silico approaches. ( Ramachandran, V; Saravanan, R; Senthilraja, P, 2014) |
| "Hyperlipidemia occurs in GDM." | 1.36 | Impact of hyperlipidemia on plasma protein binding and hepatic drug transporter and metabolic enzyme regulation in a rat model of gestational diabetes. ( Anger, GJ; Piquette-Miller, M, 2010) |
| "Diabetes, when uncontrolled, causes dyslipidemia often followed by atherogenic abnormalities." | 1.32 | Protective effects of ferulic acid on hyperlipidemic diabetic rats. ( Menon, VP; Rukkumani, R; Sri Balasubashini, M, 2003) |
| "Because both type 2 diabetes and elevated plasma lipid levels are important independent risk factors for cardiovascular disease and coronary heart disease, the choice of an antihyperglycemic agent for patients with type 2 diabetes--in whom abnormal plasma lipid levels are often seen-should take into account effects on lipids as well as on markers of glycemic control." | 1.31 | Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study. ( Dailey, GE; Fiedorek, FT; Mohideen, P, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Nazir, N | 1 |
| Zahoor, M | 1 |
| Ullah, R | 1 |
| Ezzeldin, E | 1 |
| Mostafa, GAE | 1 |
| Sadri, H | 1 |
| Larki, NN | 1 |
| Kolahian, S | 1 |
| Ezeigbo, II | 1 |
| Asuzu, IU | 1 |
| Ramachandran, V | 1 |
| Saravanan, R | 1 |
| Senthilraja, P | 1 |
| Anger, GJ | 1 |
| Piquette-Miller, M | 1 |
| Boopathy Raja, A | 1 |
| Elanchezhiyan, C | 1 |
| Sethupathy, S | 1 |
| Kaimal, S | 1 |
| Sujatha, KS | 1 |
| George, S | 1 |
| Sen, S | 1 |
| Roy, M | 1 |
| Chakraborti, AS | 1 |
| Huseini, HF | 1 |
| Kianbakht, S | 1 |
| Hajiaghaee, R | 1 |
| Dabaghian, FH | 1 |
| Dailey, GE | 1 |
| Mohideen, P | 1 |
| Fiedorek, FT | 1 |
| Akbar, DH | 1 |
| Sri Balasubashini, M | 1 |
| Rukkumani, R | 1 |
| Menon, VP | 1 |
| Yosefy, C | 1 |
| Magen, E | 1 |
| Kiselevich, A | 1 |
| Priluk, R | 1 |
| London, D | 1 |
| Volchek, L | 1 |
| Viskoper, RJ | 1 |
| Mori, Y | 2 |
| Kitahara, Y | 1 |
| Miura, K | 1 |
| Mine, T | 1 |
| Tajima, N | 2 |
| Itoh, Y | 1 |
| Obata, T | 1 |
| Janka, HU | 1 |
| Standl, A | 1 |
| Holler, HD | 1 |
| Mehnert, H | 1 |
| Nakamura, N | 1 |
| Hamazaki, T | 1 |
| Jokaji, H | 1 |
| Minami, S | 1 |
| Kobayashi, M | 1 |
| Sriram, U | 1 |
| Spallarossa, P | 1 |
| Schiavo, M | 1 |
| Rossettin, P | 1 |
| Cordone, S | 1 |
| Olivotti, L | 1 |
| Cordera, R | 1 |
| Brunelli, C | 1 |
| Nakamura, T | 1 |
| Ushiyama, C | 1 |
| Osada, S | 1 |
| Shimada, N | 1 |
| Ebihara, I | 1 |
| Koide, H | 1 |
| Simons, LA | 1 |
| Myant, NB | 1 |
1 review available for glyburide and Hyperlipemia
| Article | Year |
|---|---|
Post-prandial hyperglycemia and its implications in pregnancy and lipid abnormalities.
Topics: Female; Glyburide; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Postprandial Period; | 2001 |
8 trials available for glyburide and Hyperlipemia
| Article | Year |
|---|---|
Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial.
Topics: Adult; Aloe; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gels; Glyburide; Humans; Hyperc | 2012 |
Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome.
Topics: Blood Glucose; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Glyburide; Hu | 2003 |
Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity.
Topics: Administration, Oral; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Brachial Artery; | 2004 |
Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fatty Acids, Nones | 2006 |
[Carbohydrate metabolism in bezafibrate therapy. Controlled study of glibenclamide-treated diabetics with hyperlipidemia].
Topics: Aged; Bezafibrate; Carbohydrate Metabolism; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Di | 1982 |
Effect of HMG-CoA reductase inhibitors on plasma polyunsaturated fatty acid concentrations in patients with hyperlipidemia.
Topics: Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Fatty Acids, Unsaturated; Female; Gl | 1998 |
Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia.
Topics: Aged; Aged, 80 and over; Blood Pressure; Brachial Artery; Diabetes Mellitus, Type 2; Diet, Diabetic; | 2001 |
Effect of pioglitazone on dyslipidemia in hemodialysis patients with type 2 diabetes.
Topics: Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hyperli | 2001 |
12 other studies available for glyburide and Hyperlipemia
| Article | Year |
|---|---|
Curative Effect of Catechin Isolated from
Topics: alpha-Amylases; alpha-Glucosidases; Animals; Antioxidants; Benzothiazoles; Biphenyl Compounds; Blood | 2020 |
Hypoglycemic and Hypolipidemic Effects of Leucine, Zinc, and Chromium, Alone and in Combination, in Rats with Type 2 Diabetes.
Topics: Animals; Blood Glucose; Chromium; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dietary Supp | 2017 |
Anti-diabetic activities of the methanol leaf extracts of Hymenocardia acida (tul.) in alloxan-induced diabetic rats.
Topics: Animals; Biomarkers; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Euphorbiacea | 2012 |
Antidiabetic and antihyperlipidemic activity of asiatic acid in diabetic rats, role of HMG CoA: in vivo and in silico approaches.
Topics: Acyl Coenzyme A; Animals; Blood Glucose; Centella; Cholesterol; Diabetes Mellitus, Experimental; Gly | 2014 |
Impact of hyperlipidemia on plasma protein binding and hepatic drug transporter and metabolic enzyme regulation in a rat model of gestational diabetes.
Topics: Animals; Binding, Competitive; Biological Transport; Blood Proteins; Carrier Proteins; Chromatograph | 2010 |
Antihyperlipidemic activity of Helicteres isora fruit extract on streptozotocin induced diabetic male Wistar rats.
Topics: Animals; Diabetes Mellitus, Experimental; Fruit; Glyburide; Hyperlipidemias; Hypoglycemic Agents; Hy | 2010 |
Hypolipidaemic and antioxidant effects of fruits of Musa AAA (Chenkadali) in alloxan induced diabetic rats.
Topics: Alanine Transaminase; Alloxan; Animals; Antioxidants; Cholesterol; Diabetes Mellitus, Experimental; | 2010 |
Ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats.
Topics: Animals; Blood Glucose; Catalase; Cholesterol; Diabetes Mellitus, Experimental; Free Radicals; Fruct | 2011 |
Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
Topics: Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type | 2002 |
Protective effects of ferulic acid on hyperlipidemic diabetic rats.
Topics: Administration, Oral; Animals; Coumaric Acids; Diabetes Mellitus, Experimental; Fatty Acids, Noneste | 2003 |
Role of early insulin secretion in postglucose-loading hyperglycaemia and postfat-loading hyperlipidaemia: comparing nateglinide and glibenclamide for acute effects on insulin secretion in OLETF rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Dietary Fats; Gene | 2004 |
Cholesterol metabolism in hypertriglyceridaemia and the effects of treatment.
Topics: Adult; Alcohol Drinking; Bile Acids and Salts; Cholesterol; Chylomicrons; Diabetes Complications; Di | 1975 |